Today, Explained Why little kids don’t have vaccines
May 5, 2022
In this discussion, Lauren Gardner, a Politico reporter specializing in FDA coverage, dives into the complex landscape of COVID-19 vaccinations for young children. She highlights the slow approval processes affecting kids under five, revealing the emotional toll on concerned parents. The conversation also explores how the pandemic has impacted infant development and preschoolers’ social skills due to missed educational opportunities. Gardner provides valuable insights into vaccine hesitancy and the challenges faced by parents eager for their children's protection.
AI Snips
Chapters
Transcript
Episode notes
Vaccine Delays for Under-Fives
- The FDA prioritizes a vaccine for children under five, but the process is complex.
- The Omicron variant complicated data collection during trials, causing delays and frustration for parents.
Moderna Vaccine Submission
- Moderna submitted a vaccine application for kids under six.
- The FDA is cautiously optimistic about a potential timeline without overpromising, given past frustrations.
Pediatric Vaccine Dosage
- Pediatric vaccine doses differ from adult doses.
- Despite being smaller, these doses produce a similar immune response in children, protecting them from the virus.